Mounjaro Cost in Delaware (2026)
Affordability Score™ · DE
Mounjaro (tirzepatide) lists at $1,112/month in Delaware. Lilly's savings card and commercial diabetes coverage often bring copays to $25–$100/month.
Quick answer
Mounjaro (tirzepatide) lists at $1,112/month in Delaware (2026). With commercial insurance and a savings card, many patients pay $25–$100/month — use the calculator below for your estimate.
Delaware market notes for Mounjaro (tirzepatide)
For Mounjaro (tirzepatide, diabetes) in Delaware, Lilly savings-card math applies on commercial diabetes claims; do not assume the same copay if your physician writes tirzepatide for weight loss under a Zepbound NDC. Delaware (DE) GLP-1 pricing follows national list prices adjusted by local pharmacy competition, employer formulary design, and whether Medicaid or Medicare Advantage dominates the insurance mix. Commercial plans in Delaware commonly require prior authorization for obesity-indicated brands (Wegovy, Zepbound) while diabetes paths for Ozempic or Mounjaro clear more reliably when medically indicated. Manufacturer savings cards usually exclude government insurance—so Medicare, Medicaid, TRICARE, and VA patients in Delaware need a separate model than the “$25/month” ads. Before you commit, get a written pharmacy quote for the exact NDC, confirm PA status with your insurer, and compare mail-order specialty copays against a local cash fill.
State cost index modifier: 1× · List ~$1,112/mo · Card path typically $25–$100/mo when eligible.
Free comparison
Compare GLP-1 options in Delaware
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Affordability audit
Step 1 — Pick your medication
Affordability Score™ is an educational estimate — not medical, insurance, or pharmacy advice.
All GLP-1 prices — DE
| Medication | List/mo | With card | Cash programs |
|---|---|---|---|
| Ozempic (semaglutide) | $969 | $25 – $100 | $349 – $499 |
| Wegovy (semaglutide) | $1,349 | $25 – $100 | $349 – $499 |
| Mounjaro (tirzepatide) | $1,112 | $25 – $100 | $349 – $499 |
| Zepbound (tirzepatide) | $1,086 | $25 – $100 | $349 – $499 |
Other GLP-1 drugs in Delaware
What affects Mounjaro (tirzepatide) cost in Delaware?
- Insurance type and whether your plan covers Type 2 diabetes
- Prior authorization and BMI requirements
- Manufacturer savings card eligibility
- Delaware regional cost index (modifier 1×)
- Compounded alternatives vs brand tirzepatide
Medicare & Medicaid — Delaware
Wegovy/Zepbound for weight loss are generally not covered by Medicare Part D as of 2026.
Related pages
Frequently Asked Questions
How much does Mounjaro (tirzepatide) cost in Delaware without insurance?
List price in Delaware is about $1,112/month. Cash discount programs may reduce cost to $349–$499/month; compounded tirzepatide runs $199–$399/month via telehealth.
Does insurance cover Mounjaro (tirzepatide) in Delaware?
Eli Lilly markets Mounjaro for Type 2 diabetes. Commercial plans often require prior authorization; Medicare coverage depends on indication. See our <a href="/guides/glp1-prior-authorization/" class="text-accent-400 underline">prior auth guide</a>.
What is the cheapest way to get Mounjaro in Delaware?
With insurance + manufacturer savings card, eligible patients often pay $25–$100/month. Run the <a href="/affordability-audit/" class="text-accent-400 underline">Affordability Audit</a> for your scenario.
How does Delaware compare to other states for Mounjaro cost?
Delaware uses a regional cost modifier of 1× vs national average. See <a href="/glp1-state-rankings/" class="text-accent-400 underline">50-state Affordability Rankings</a>.
How We Estimate GLP-1 Costs
MetaDose estimates combine manufacturer list prices (Novo Nordisk, Eli Lilly), NovoCare/LillyDirect cash programs, and state pharmacy cost indices — updated 2026-07-15.
Updated 2026-07-15. Novo Nordisk list prices, Lilly list prices, NovoCare/LillyDirect cash programs, GoodRx averages. Educational estimates only.